CROI 2020 Program and Conference Information

Poster Sessions

Poster P-D06 THE ROAD TO A BETTER VACCINE: CLINICAL TRIALS AND COHORT STUDIES Poster Hall A 2:30 PM - 4:00 PM 287 THE RV144VACCINE PRIMED IgG4 ANDV1V2-ADCP RESPONSES INHIV BREAKTHROUGH INFECTIONS Thembi Mdluli , Dominic Paquin-Proulx, Bonnie Slike, Gina Donofrio, Sorachai Nitayaphan, Punnee Pitisutthithum, Supachai Rerks-Ngarm, Margaret Ackerman, Merlin L. Robb, Nelson L. Michael, Sandhya Vasan, Michael A. Eller, Shelly J. Krebs, Morgane Rolland, for the RV144 Study Group 288 PHASE I/IIA TRIAL OF HIV CLADE C DNAWITHMF59- OR AS01B- ADJUVANTED CLADE C PROTEIN Nigel Garrett , Cynthia L. Monaco, Philipp Mann, Julia Hutter, Allan C. deCamp, One Dintwe, Georgia Tomaras, Megan Jones, Giuseppe Pantaleo, Song Ding, Olivier Van Der Meeren, Julie McElrath, Larry Corey, James G. Kublin, for the HVTN 108 Study Team 289 MUCOSAL T AND B CELL RESPONSES INDUCED BY ALVAC-HIV/ AIDSVAX B/E LATE BOOST STRATEGIES Alexandra Schuetz , Siriwat Akapirat, Michael A. Eller, Yuwadee Phuang- Ngern, Punnee Pitisutthithum, Sorachai Nitayaphan, Suwat Chariyalertsak, Nittaya Phanuphak, Carlos A. Diazgranados, Jerome H. Kim, Merlin L. Robb, Nelson L. Michael, Robert J. O'Connell, Sandhya Vasan, for the RV306 Study Group 290 CANDIDATE IMMUNOGENS DIFFERENTIALLY ENGAGE HIV BROADLY NEUTRALIZING PLASMA ANTIBODIES Irene Abela , Teja Turk, Nikolas Friedrich, Claus Kadelka, Matthias Gloegl, Brano Ivan, Peter Rusert, Merle Schanz, Roger Kouyos, Huldrych F. Günthard, Alexandra Trkola, for the Swiss HIV Cohort Study 291 ACUTE INFECTION B-CELL DETERMINANTS PREDICT DEVELOPMENT OF NEUTRALIZATION BREADTH Samantha Townsley, Gina Donofrio, Ningbo Jian, David Leggat, Vincent Dussupt, Letzibeth Mendez-Rivera, Nicole Doria-Rose, John R. Mascola, Morgane Rolland, Sodsai Tovanabutra, Adrian B. McDermott, Nelson L. Michael, Merlin L. Robb, Shelly J. Krebs , for the RV217 Study Group 292 TARGETING HIV ENV TO CD40 LEADS TO HIV-SPECIFIC POLYCLONAL B CELLS INHUMANIZEDMICE Veronique Godot , Colas Tcherakian, Laurine Gil, Iñaki Cervera-Marzal, Hugo Mouquet, Guangming Li, Liang Cheng, Jean Daniel Lelievre, Giuseppe Pantaleo, Mireille Centlivre, Sandy Zurawski, Gerard Zurawski, Pierre Milpied, Lishan Su, Yves Levy 293 CD40-TARGETEDVACCINE INCREASESMAGNITUDE OF HIV-ENV SPECIFIC RESPONSES Romain Marlin, Sabine Tricot, Francis Relouzat, Christiane Moog, Laëtitia Bossevot, Sandy Zurawski, Gerard Zurawski, Andrès Salazar, Catherine Chapon, Nathalie Dereuddre-Bosquet, Mireille Centlivre, Yves Levy, Roger Le Grand 294 HARNESSING ORIGINAL ANTIGENIC SIN FOR PREVENTINGMTCT OF HIV Ashley N. Nelson , Maria Dennis, Jesse F. Mangold, Katherine N. Li, Riley J. Mangan, George Shaw, Katharine J. Bar, Barton F. Haynes, M. Anthony Moody, Justin Pollara, Koen Van Rompay, Kristina De Paris, Sallie Permar Poster P-D07 PRECLINICAL VACCINE STUDIES Poster Hall A 2:30 PM - 4:00 PM

Poster Sessions • Wednesday

CROI 2020 142